Literature DB >> 28638858

Endocannabinoid metabolism in neurodegenerative diseases.

Chu Chen1.   

Abstract

Entities:  

Year:  2016        PMID： 28638858      PMCID： PMC5476313          DOI： 10.20517/2347-8659.2016.46

Source DB:  PubMed          Journal:  Neuroimmunol Neuroinflamm        ISSN： 2347-8659


× No keyword cloud information.
  15 in total

Review 1.  Endocannabinoid-mediated control of synaptic transmission.

Authors:  Masanobu Kano; Takako Ohno-Shosaku; Yuki Hashimotodani; Motokazu Uchigashima; Masahiko Watanabe
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

Review 2.  Traumatic Brain Injury as a Risk Factor for Alzheimer's Disease: Is Inflammatory Signaling a Key Player?

Authors:  Jelena Djordjevic; Mohammad Golam Sabbir; Benedict C Albensi
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

3.  Synaptic and cognitive improvements by inhibition of 2-AG metabolism are through upregulation of microRNA-188-3p in a mouse model of Alzheimer's disease.

Authors:  Jian Zhang; Mei Hu; Zhaoqian Teng; Ya-Ping Tang; Chu Chen
Journal:  J Neurosci       Date:  2014-11-05       Impact factor: 6.167

4.  Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ.

Authors:  Huizhi Du; Xiaolei Chen; Jian Zhang; Chu Chen
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

5.  Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation.

Authors:  Daniel K Nomura; Bradley E Morrison; Jacqueline L Blankman; Jonathan Z Long; Steven G Kinsey; Maria Cecilia G Marcondes; Anna M Ward; Yun Kyung Hahn; Aron H Lichtman; Bruno Conti; Benjamin F Cravatt
Journal:  Science       Date:  2011-10-20       Impact factor: 47.728

6.  An endogenous cannabinoid (2-AG) is neuroprotective after brain injury.

Authors:  D Panikashvili; C Simeonidou; S Ben-Shabat; L Hanus; A Breuer; R Mechoulam; E Shohami
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

7.  Inhibition of monoacylglycerol lipase prevents chronic traumatic encephalopathy-like neuropathology in a mouse model of repetitive mild closed head injury.

Authors:  Jian Zhang; Zhaoqian Teng; Yunping Song; Mei Hu; Chu Chen
Journal:  J Cereb Blood Flow Metab       Date:  2014-12-10       Impact factor: 6.200

Review 8.  Endocannabinoids in synaptic plasticity and neuroprotection.

Authors:  Jian-Yi Xu; Chu Chen
Journal:  Neuroscientist       Date:  2014-02-25       Impact factor: 7.519

Review 9.  Endocannabinoid signaling and synaptic function.

Authors:  Pablo E Castillo; Thomas J Younts; Andrés E Chávez; Yuki Hashimotodani
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

10.  Endocannabinoid 2-arachidonoylglycerol protects neurons by limiting COX-2 elevation.

Authors:  Jian Zhang; Chu Chen
Journal:  J Biol Chem       Date:  2008-06-05       Impact factor: 5.157
View more
  3 in total

1.  Alleviation of Neuropathology by Inhibition of Monoacylglycerol Lipase in APP Transgenic Mice Lacking CB2 Receptors.

Authors:  Jian Zhang; Chu Chen
Journal:  Mol Neurobiol       Date:  2017-07-21       Impact factor: 5.590

2.  Inhibition of 2-Arachidonoylglycerol Metabolism Alleviates Neuropathology and Improves Cognitive Function in a Tau Mouse Model of Alzheimer's Disease.

Authors:  Jack Hashem; Mei Hu; Jian Zhang; Fei Gao; Chu Chen
Journal:  Mol Neurobiol       Date:  2021-05-03       Impact factor: 5.682

Review 3.  Endocannabinoid Metabolism and Traumatic Brain Injury.

Authors:  Dexiao Zhu; Fei Gao; Chu Chen
Journal:  Cells       Date:  2021-11-02       Impact factor: 6.600
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.